SAM
NARI

Smartleaf Asset Management’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Smartleaf Asset Management’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-634
Closed -$32.9K – 3034
2024
Q4 		$32.9K Buy
634
+356
+128% +$17.5K ﹤0.01% 1384
2024
Q3 		$11.5K Buy
278
+127
+84% +$6.1K ﹤0.01% 1678
2024
Q2 		$7.09K Buy
+151
New +$6.69K ﹤0.01% 1606

Other funds holding NARI

SA
SoundView Advisors Olympia, Washington $281M AUM 17.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return

Smartleaf Asset Management's NARI Position: Q1 2025 in Review

Smartleaf Asset Management sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 634 shares — an estimated $32.9K sold.

Smartleaf Asset Management first reported a position in NARI in Q2 2024 and held it in 3 quarters. The position peaked at $32.9K in Q4 2024. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Smartleaf Asset Management reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Smartleaf Asset Management sold 634 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $32.9K.
  • Smartleaf Asset Management first reported a position in Inari Medical, Inc. Common Stock in Q2 2024 and held it in 3 quarters.
  • Smartleaf Asset Management's Inari Medical, Inc. Common Stock position peaked at $32.9K in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Smartleaf Asset Management's 13F filing for Q1 2025, filed 14 May 2025.